![](/img/cover-not-exists.png)
TARGET ENGAGEMENT IN AN AD TRIAL: CRENEZUMAB LOWERS Aβ OLIGOMER LEVELS IN CSF
Yang, Ting, Dang, Yifan, Ostaszewski, Beth, Mengel, David, Steffen, Verena, Rabe, Christina, Bittner, Tobias, Walsh, Dominic M., Selkoe, Dennis J.Volume:
14
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2018.07.012
Date:
July, 2018
File:
PDF, 420 KB
english, 2018